{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:54Z","timestamp":1793407854210,"version":"4.5.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cervical cancer (CC) remains a major global health threat closely associated with persistent high-risk human papillomavirus (HPV) infection. Although immune checkpoint inhibitors (ICIs) have emerged as a therapeutic option, their objective response rates remain unsatisfactory. Variations in the local vaginal microbiota alone cannot fully explain inter-individual differences in HPV clearance, suggesting that additional systemic immune determinants are involved. The gut microbiota, a central regulator of host systemic immunity, can profoundly influence HPV clearance and antitumor immune responses by shaping dendritic cell (DC) function, modulating the Th1\/Th2 balance, regulating regulatory T cell (Treg) expansion, and affecting natural killer (NK) cell activity. Emerging evidence indicates that specific gut microbial taxa are causally associated with HPV infection, cervical intraepithelial neoplasia (CIN), and cervical cancer, and may reshape the vaginal microecological environment and enhance immunotherapy responses. However, this dimension has long received insufficient attention. This Perspective systematically addresses four core issues: the neglected status of gut microbiota research and the functional boundaries of vaginal microecology; key mechanisms through which gut microbiota regulate HPV clearance and cervical lesion progression; major challenges restricting progress; and potential strategies for promoting clinical translation. This work aims to establish a theoretical framework for gut microbiota\u2013based interventions in cervical cancer prevention and treatment, providing directional guidance for this emerging interdisciplinary field.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1826283","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:20:48Z","timestamp":1779949248000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of gut microbiota on cervical cancer and precancerous lesions: neglected status, mechanisms, challenges, and a call to action"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanfang","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gynecology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Fourth Hospital of Shijiazhuang","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songxiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengbin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35369","article-title":"Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer","volume":"157","author":"Li","year":"2025","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: Results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","article-title":"Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: Systematic review and meta-analysis","volume":"221","author":"Brusselaers","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15854","article-title":"The vaginal microbiota, human papillomavirus and cervical dysplasia: A systematic review and network meta-analysis","volume":"127","author":"Norenhag","year":"2020","journal-title":"BJOG"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.540900","article-title":"Vaginal microbiota and cytokine microenvironment in HPV clearance\/persistence in women surgically treated for cervical intraepithelial neoplasia: An observational prospective study","volume":"10","author":"Caselli","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008376","article-title":"Cervicovaginal microbiome and natural history of HPV in a longitudinal study","volume":"16","author":"Usyk","year":"2020","journal-title":"PloS Pathog"},{"key":"B8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pvr.2017.08.002","article-title":"Modulation of antigen presenting cell functions during chronic HPV infection","volume":"4","author":"Bashaw","year":"2017","journal-title":"Papillomavirus Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1637098","article-title":"Microbiota-immune dysregulation in cervical cancer patients from Western Mexico: Linking gut dysbiosis and NK cell exhaustion as promising biomarkers","volume":"16","author":"Klimov-Kravtchenko","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22894","article-title":"CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia","volume":"121","author":"Molling","year":"2007","journal-title":"Int J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12985-022-01776-4","article-title":"Increased expression of TIGIT and KLRG1 correlates with impaired CD56bright NK cell immunity in HPV16-related cervical intraepithelial neoplasia","volume":"19","author":"Nie","year":"2022","journal-title":"Virol J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1336101","article-title":"The causal correlation between gut microbiota abundance and pathogenesis of cervical cancer: A bidirectional mendelian randomization study","volume":"15","author":"Yang","year":"2024","journal-title":"Front Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1038\/s41598-025-00483-8","article-title":"Dynamic causal effects of gut microbiota on cervical cancer lesion progression","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-606X.21.04752-7","article-title":"Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: Results of a preliminary, uncontrolled, open trial","volume":"73","author":"Di Pierro","year":"2021","journal-title":"Minerva Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85880","article-title":"Role of vaginal and gut microbiota in human papillomavirus (HPV) progression and cervical cancer: A systematic review of microbial diversity and probiotic interventions","volume":"17","author":"Pai","year":"2025","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127857","article-title":"Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential","volume":"287","author":"Huang","year":"2024","journal-title":"Microbiol Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz325","article-title":"Associations of cervicovaginal lactobacilli with high-risk human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: A systematic review and meta-analysis","volume":"220","author":"Wang","year":"2019","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.21276\/ssr-iijls.2022.8.4.3","article-title":"Meta-analysis and systematic review of the relationship between cervical lesions, HPV and vaginal community state type","volume":"8","author":"Pan","year":"2022","journal-title":"SSR Institute Int J Life Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41598-019-43849-5","article-title":"Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis","volume":"9","author":"\u0141aniewski","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02785-18","article-title":"Relationship between the cervical microbiome, HIV status, and precancerous lesions","volume":"10","author":"Klein","year":"2019","journal-title":"mBio"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248639","article-title":"IL-6 and IL-10 in the serum and exfoliated cervical cells of patients infected with high-risk human papillomavirus","volume":"16","author":"Bonin-Jacob","year":"2021","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28119","article-title":"Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study","volume":"133","author":"Scott","year":"2013","journal-title":"Int J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01676","article-title":"E6\/E7 and E6* from HPV16 and HPV18 upregulate IL-6 expression independently of p53 in keratinocytes","volume":"10","author":"Artaza-Irigaray","year":"2019","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400216","article-title":"IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia","volume":"193","author":"Gosmann","year":"2014","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.04.008","article-title":"Interleukin-17 expression in the serum and exfoliated cervical cells of patients infected with high-risk oncogenic human papillomavirus","volume":"120","author":"Mareti Bonin","year":"2019","journal-title":"Cytokine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045201","article-title":"Association between bacterial vaginosis and cervical intraepithelial neoplasia: Systematic review and meta-analysis","volume":"7","author":"Gillet","year":"2012","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13027-019-0243-8","article-title":"A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia","volume":"14","author":"Liang","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/s41598-020-80176-6","article-title":"Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia","volume":"11","author":"Kawahara","year":"2021","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41467-021-27628-3","article-title":"molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history","volume":"13","author":"Usyk","year":"2022","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.955150","article-title":"Vaginal microbiota and HPV clearance: A longitudinal study","volume":"12","author":"Shi","year":"2022","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000494985","article-title":"From HPV infection to lesion progression: The role of HLA alleles and host immunity","volume":"63","author":"Paaso","year":"2019","journal-title":"Acta Cytol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001718","article-title":"Association between human leukocyte antigen polymorphism and human papillomavirus infection in Brazilian women","volume":"50","author":"de Araujo-Souza","year":"2023","journal-title":"Sex Transm Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1038\/s41598-020-64268-x","article-title":"Identifying the HLA DRB1-DQB1 molecules and predicting epitopes associated with high-risk HPV infection clearance and redetection","volume":"10","author":"Del R\u00edo-Ospina","year":"2020","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1038\/s41467-021-26151-9","article-title":"Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer","volume":"12","author":"Ferreiro-Iglesias","year":"2021","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00357-23","article-title":"The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status","volume":"8","author":"Vargas-Robles","year":"2023","journal-title":"mSystems"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-24-0286","article-title":"Viewing Native American cervical cancer disparities through the lens of the vaginal microbiome: A pilot study","volume":"17","author":"\u0141aniewski","year":"2024","journal-title":"Cancer Prev Res (Phila)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00683-25","article-title":"Lactobacillus crispatus-derived nCEV vesicles promote cutaneous wound healing and inhibit HPV16 infection","volume":"10","author":"Peng","year":"2025","journal-title":"mSystems"},{"key":"B40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/acsinfecdis.0c00839","article-title":"Gut microbiota and gynecological cancers: A summary of pathogenetic mechanisms and future directions","volume":"7","author":"Borella","year":"2021","journal-title":"ACS Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-00987-1","article-title":"Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity","volume":"20","author":"Kim","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: Linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02184","article-title":"Female gut and genital tract microbiota-induced crosstalk and differential effects of short-chain fatty acids on immune sequelae","volume":"11","author":"Amabebe","year":"2020","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.609488","article-title":"The interaction between microorganisms, metabolites, and immune system in the female genital tract microenvironment","volume":"10","author":"Li","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14562","article-title":"Microbiota metabolites in the female reproductive system: Focused on the short-chain fatty acids","volume":"9","author":"Mirzaei","year":"2023","journal-title":"Heliyon"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.2c00305","article-title":"Correlation of the gut microbiota and antitumor immune responses induced by a human papillomavirus therapeutic vaccine","volume":"8","author":"Che","year":"2022","journal-title":"ACS Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2022.04.006","article-title":"The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis","volume":"55","author":"Erttmann","year":"2022","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09249-8","article-title":"Microbiota-driven antitumour immunity mediated by dendritic cell migration","volume":"644","author":"Lin","year":"2025","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"Stanley","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"deaf097.301","DOI":"10.1093\/humrep\/deaf097.301","article-title":"O-301 can a healthy gut modulate the cervicovaginal immune response to an adverse vaginal microbiota","volume":"40","author":"Grewal","year":"2025","journal-title":"Hum Reprod"},{"key":"B52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12916-024-03500-1","article-title":"Vaginal and rectal microbiome contribute to genital inflammation in chronic pelvic pain","volume":"22","author":"Jimenez","year":"2024","journal-title":"BMC Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1007\/s12672-025-03717-3","article-title":"Gut microbiota and risk of cervical cancer: a Mendelian multivariable randomization study","volume":"16","author":"Lu","year":"2025","journal-title":"Discov Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037628","article-title":"Associations between gut microbiota and gynecological cancers: a bi-directional two-sample Mendelian randomization study","volume":"103","author":"Kong","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41467-020-15856-y","article-title":"The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions","volume":"11","author":"Mitra","year":"2020","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.01.006","article-title":"Fecal microbiota transplantation in clinical practice: present controversies and future prospects","volume":"2","author":"Tian","year":"2024","journal-title":"hLife"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-024-04915-7","article-title":"The association between lifestyle factors and the composition of the vaginal microbiota: a review","volume":"43","author":"Morsli","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac094","article-title":"The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle","volume":"37","author":"Krog","year":"2022","journal-title":"Hum Reprod"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1582283","article-title":"Dietary habits and vaginal environment: can a beneficial impact be expected","volume":"15","author":"Djusse","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1158\/1940-6207.CAPR-20-0103","article-title":"Effect of antibiotics on gut and vaginal microbiomes associated with cervical cancer development in mice","volume":"13","author":"Karpinets","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/aji.70026","article-title":"Vaginal microbiome: environmental, biological, and racial influences on gynecological health across the lifespan","volume":"92","author":"Dub\u00e9-Zinatelli","year":"2024","journal-title":"Am J Reprod Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"188990","DOI":"10.1016\/j.bbcan.2023.188990","article-title":"Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: an emerging trend in cancer patient care","volume":"1878","author":"Ciernikova","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1505656","article-title":"Focus on gut microbes: new direction in cancer treatment","volume":"15","author":"Liao","year":"2025","journal-title":"Front Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2024.07.008","article-title":"Navigating beyond associations: opportunities to establish causal relationships between the gut microbiome and colorectal carcinogenesis","volume":"32","author":"Baas","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1186\/s12864-025-12282-6","article-title":"A systematic longitudinal study of microbiome: integrating temporal-spatial dimensions with causal and deep learning models","volume":"26","author":"Wang","year":"2025","journal-title":"BMC Genomics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2147\/IJWH.S406596","article-title":"Imbalance of vaginal microbiota and immunity: two main accomplices of cervical cancer in Chinese women","volume":"15","author":"Li","year":"2023","journal-title":"Int J Womens Health"},{"key":"B68","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1038\/s41598-018-25879-7","article-title":"Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women","volume":"8","author":"\u0141aniewski","year":"2018","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.04.028","article-title":"Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling","volume":"44","author":"Ilhan","year":"2019","journal-title":"EBioMedicine"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.07.013","article-title":"Microbes in gynecologic cancers: causes or consequences and therapeutic potential","volume":"86","author":"Wahid","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"36881","DOI":"10.1038\/s41598-025-20838-5","article-title":"Effect of orally administered L. crispatus M247 in favoring HR-HPV clearance and CST shift: results from a randomized, multi-center, placebo-controlled trial","volume":"15","author":"Di Pierro","year":"2025","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"pkad101","DOI":"10.1093\/jncics\/pkad101","article-title":"Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3","volume":"7","author":"Kawana","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.chom.2024.06.010","article-title":"Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor","volume":"32","author":"Kim","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","article-title":"Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy","volume":"164","author":"Chrysostomou","year":"2023","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s41065-025-00483-8","article-title":"METTL3 mediates m6A methylation modification of ULBP2 and affects the progression of cervical cancer","volume":"162","author":"Ren","year":"2025","journal-title":"Hereditas"},{"key":"B77","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41573-025-01211-7","article-title":"The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development","volume":"24","author":"Elkrief","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.01.008","article-title":"AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases","volume":"166","author":"Peery","year":"2024","journal-title":"Gastroenterology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2024.1434799","article-title":"Advanced computational tools, artificial intelligence and machine-learning approaches in gut microbiota and biomarker identification","volume":"6","author":"Dakal","year":"2024","journal-title":"Front Med Technol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.02.035","article-title":"Machine learning and artificial intelligence in the multi-omics approach to gut microbiota","volume":"169","author":"Rozera","year":"2025","journal-title":"Gastroenterology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17415","article-title":"Altered vaginal cervical microbiota diversity contributes to HPV-induced cervical cancer via inflammation regulation","volume":"12","author":"Yang","year":"2024","journal-title":"PeerJ"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330291","article-title":"Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells","volume":"72","author":"Kang","year":"2023","journal-title":"Gut"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.884272","article-title":"Altered vaginal microbiota composition correlates with human papillomavirus and mucosal immune responses in women with symptomatic cervical ectopy","volume":"12","author":"L\u00f3pez-Filloy","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microbes"},{"key":"B86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12866-025-03922-8","article-title":"The inferred modulation of correlated vaginal microbiota and metabolome by cervical differentially expressed genes across distinct CIN grades","volume":"25","author":"Dai","year":"2025","journal-title":"BMC Microbiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.3390\/cancers15194878","article-title":"The relationship between Furin and chronic inflammation in the progression of cervical intraepithelial neoplasia to cancer: a cross-sectional study","volume":"15","author":"Afsar","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1574511","article-title":"The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer","volume":"15","author":"Guo","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12985-023-02039-6","article-title":"Peripheral blood lymphocytes influence human papillomavirus infection and clearance: a retrospective cohort study","volume":"20","author":"Li","year":"2023","journal-title":"Virol J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"A76","DOI":"10.1136\/sextrans-2019-sti.195","article-title":"O16.3 cytokine immune response against natural human papillomavirus infection among men in Kisumu, Kenya","volume":"95","author":"Ondondo","year":"2019","journal-title":"Sex Transm Infect"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2024.25.5.1635","article-title":"Inflammatory markers in prior loop electrosurgical excision procedure (LEEP) as a prognosis factor in the recurrence of cervical intraepithelial neoplasia","volume":"25","author":"Bunpreenant","year":"2024","journal-title":"Asian Pac J Cancer Prev"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.3390\/jcm14124059","article-title":"Prognostic value of systemic inflammatory response markers for CIN2+ recurrence after loop electrosurgical excision procedure: a retrospective cohort study","volume":"14","author":"Katran","year":"2025","journal-title":"J Clin Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03693-9","article-title":"Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer","volume":"31","author":"Piccinno","year":"2025","journal-title":"Nat Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100868","article-title":"A systematic review of microbiome-derived biomarkers for early colorectal cancer detection","volume":"36","author":"Zwezerijnen-Jiwa","year":"2023","journal-title":"Neoplasia"},{"key":"B95","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12967-023-04411-0","article-title":"Weighted gene coexpression network analysis and machine learning reveal oncogenome associated microbiome plays an important role in tumor immunity and prognosis in pan-cancer","volume":"21","author":"Guan","year":"2023","journal-title":"J Transl Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"TPS5622","DOI":"10.1200\/jco.2025.43.16_suppl.tps5622","article-title":"A phase II, single-arm, open-label clinical trial to evaluate the combination of cadonilimab injection and gut microbiota modulation in the treatment of persistent, recurrent, or metastatic cervical cancer following second-line therapy","volume":"43","author":"Xu","year":"2025","journal-title":"J Clin Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247905","article-title":"A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers","volume":"16","author":"El Alam","year":"2021","journal-title":"PloS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen-gut microbiome axis: physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3390\/nu16152569","article-title":"Nature of the association between rheumatoid arthritis and cervical cancer and its potential therapeutic implications","volume":"16","author":"Gusakov","year":"2024","journal-title":"Nutrients"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2236749","article-title":"Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism","volume":"15","author":"Hu","year":"2023","journal-title":"Gut Microbes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1826283\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:20:49Z","timestamp":1779949249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1826283\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2026.1826283"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1826283","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1826283"}}